Springhill Fund Asset Management (Hk) CO LTD Verona Pharma PLC Transaction History
Springhill Fund Asset Management (Hk) CO LTD
- $20.9 Billion
- Q1 2025
A detailed history of Springhill Fund Asset Management (Hk) CO LTD transactions in Verona Pharma PLC stock. As of the latest transaction made, Springhill Fund Asset Management (Hk) CO LTD holds 63,499 shares of VRNA stock, worth $5.3 Million. This represents 19.32% of its overall portfolio holdings.
Number of Shares
63,499
Previous 135,452
53.12%
Holding current value
$5.3 Million
Previous $6.29 Billion
35.91%
% of portfolio
19.32%
Previous 10.22%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
291Shares Held
74.3MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$548 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$460 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$327 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$288 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$241 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $5.08B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...